Translation termination is the end stage in protein synthesis, occurring when a stop codon (UAA, UAG, or UGA) enters the A-site of the ribosome. This triggers a series of events culminating in the release of the nascent peptide and the recycling of the ribosomal subunits. The ribosome, a ribozyme, is central to this process, facilitating key interactions with eukaryotic release factors eRF1 and eRF3. eRF1 recognises the stop codon and catalyses peptide release, while eRF3, a GTPase, aids in the termination process. ABCE1, an ATPase, subsequently drives the recycling of the 60S and 40S ribosomal subunits. This project aims to reconstitute a minimal human translation termination with all necessary components to enable future direct analysis of this pivotal system.
The cloning, overexpression, and purification of two key components of the translation termination machinery, eRF1 and eRF3, was quite successful, resulting in ample production of both factors that could be used in the project's next stage. Despite initial challenges in the human 80S ribosome purification, significant amounts were successfully purified and tested. The tRNA binding assays using BODIPY-fMet-tRNA and leaderless-mRNA (sequence: “AUG UAA UC UC UC UC UC”) were performed in a stopped-flow instrument. Results showed relatively low activity of the 80S ribosome. Critically, the 70S ribosome, previously tested with XR7 mRNA (containing a strong Shine-Delgado sequence), displayed comparable activity to the 80S ribosome despite demonstrating tenfold higher fluorescence in prior experiments. This suggests that the mRNA sequence's simplicity resulted in instability and low affinity for the ribosome. A new mRNA sequence (“G AUG UAA AAAAAAAAAA") was designed with enhanced stability and affinity in mind to optimise future activity assays and progress towards translation termination assays.